
Jennifer E. Graser
Examiner (ID: 15, Phone: (571)272-0858 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1802, 1641, 1621 |
| Total Applications | 1979 |
| Issued Applications | 1306 |
| Pending Applications | 236 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18003592
[patent_doc_number] => 20220362358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS
[patent_app_type] => utility
[patent_app_number] => 17/620633
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -128
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620633 | BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS | Jun 17, 2020 | Pending |
Array
(
[id] => 18676797
[patent_doc_number] => 20230314427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => DETECTION OF ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/617802
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617802 | Detection of antigens | Jun 14, 2020 | Issued |
Array
(
[id] => 16511578
[patent_doc_number] => 20200390835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => Composition and a method for inhibiting the growth of pathogens causing bovine liver abscesses
[patent_app_type] => utility
[patent_app_number] => 16/946249
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946249 | Composition and a method for inhibiting the growth of pathogens causing bovine liver abscesses | Jun 11, 2020 | Abandoned |
Array
(
[id] => 17800182
[patent_doc_number] => 11414463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Polypeptide and immune modulation
[patent_app_type] => utility
[patent_app_number] => 16/897064
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 69
[patent_no_of_words] => 63229
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897064 | Polypeptide and immune modulation | Jun 8, 2020 | Issued |
Array
(
[id] => 17235480
[patent_doc_number] => 11179343
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Vaccine delivery systems using yeast cell wall particles
[patent_app_type] => utility
[patent_app_number] => 16/893986
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 11907
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893986 | Vaccine delivery systems using yeast cell wall particles | Jun 4, 2020 | Issued |
Array
(
[id] => 17496514
[patent_doc_number] => 11285198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Composition and method for generating immunity to
[patent_app_type] => utility
[patent_app_number] => 16/891147
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 10814
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891147 | Composition and method for generating immunity to | Jun 2, 2020 | Issued |
Array
(
[id] => 19076495
[patent_doc_number] => 11945845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Compositions and methods for regulation of chronic toxoplasma infection
[patent_app_type] => utility
[patent_app_number] => 17/595894
[patent_app_country] => US
[patent_app_date] => 2020-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 66
[patent_no_of_words] => 19208
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595894 | Compositions and methods for regulation of chronic toxoplasma infection | May 29, 2020 | Issued |
Array
(
[id] => 17420153
[patent_doc_number] => 11253582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/885568
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 11830
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885568
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885568 | None | May 27, 2020 | Issued |
Array
(
[id] => 17719077
[patent_doc_number] => 20220211796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/611720
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611720 | PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF | May 14, 2020 | Abandoned |
Array
(
[id] => 16267378
[patent_doc_number] => 20200268865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
[patent_app_type] => utility
[patent_app_number] => 15/931336
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931336 | Modulation of replicative fitness by deoptimization of synonymous codons | May 12, 2020 | Issued |
Array
(
[id] => 18232115
[patent_doc_number] => 11596659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Compositions and methods for inhibiting the proliferation of pathogenic
[patent_app_type] => utility
[patent_app_number] => 15/930394
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5767
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930394
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930394 | Compositions and methods for inhibiting the proliferation of pathogenic | May 11, 2020 | Issued |
Array
(
[id] => 20432541
[patent_doc_number] => 12502423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Vaccine immunogens
[patent_app_type] => utility
[patent_app_number] => 17/610380
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 14
[patent_no_of_words] => 7691
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610380 | Vaccine immunogens | May 10, 2020 | Issued |
Array
(
[id] => 17748190
[patent_doc_number] => 20220226393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/609795
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609795 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | May 7, 2020 | Issued |
Array
(
[id] => 20771775
[patent_doc_number] => 12655437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Compositions and methods for modulating the gastrointestinal tract using bile salt hydrolases
[patent_app_type] => utility
[patent_app_number] => 17/609283
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 23
[patent_no_of_words] => 13770
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609283 | Compositions and methods for modulating the gastrointestinal tract using bile salt hydrolases | May 6, 2020 | Issued |
Array
(
[id] => 17704910
[patent_doc_number] => 20220204916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PARASITE PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/609240
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609240
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609240 | PARASITE PURIFICATION | May 5, 2020 | Abandoned |
Array
(
[id] => 17805908
[patent_doc_number] => 20220257743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => KLEBSIELLA VACCINE AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/605591
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605591 | None | Apr 26, 2020 | Issued |
Array
(
[id] => 17843784
[patent_doc_number] => 11433127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Non-toxigenic
[patent_app_type] => utility
[patent_app_number] => 16/858029
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12032
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858029 | Non-toxigenic | Apr 23, 2020 | Issued |
Array
(
[id] => 16580703
[patent_doc_number] => 20210015105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND ANOTHER BIOLOGICAL CONTROL AGENT
[patent_app_type] => utility
[patent_app_number] => 16/857448
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/857448 | Compositions comprising recombinant | Apr 23, 2020 | Issued |
Array
(
[id] => 16221287
[patent_doc_number] => 20200246403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => YEAST EXTRACT HAVING DIABETES PREVENTION EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/856620
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/856620 | YEAST EXTRACT HAVING DIABETES PREVENTION EFFECT | Apr 22, 2020 | Abandoned |
Array
(
[id] => 17705994
[patent_doc_number] => 20220206000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS AND COMPOSITIONS USING EXTRACELLULAR VESICLES FOR THE DETECTION OF DISEASE AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/604167
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604167 | METHODS AND COMPOSITIONS USING EXTRACELLULAR VESICLES FOR THE DETECTION OF DISEASE AND DISORDERS | Apr 14, 2020 | Pending |